MedTrace Logo

A Community Pharmacy-based Program to Improve Management of Diabetes

NCT01525992 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 101

Last updated 2014-04-17

No results posted yet for this study

Summary

In this study the investigators aim to evaluate the impact of a community pharmacy-based program to educate type 2 diabetic patients about medications, life style and self-care.

Conditions

  • Diabetes Mellitus, Type 2

Interventions

BEHAVIORAL

Community pharmacist-led diabetes education program

A trained pharmacist will counsel each patient based on his/her individual needs about medications, life style and self-care. The pharmacist will use a checklist to document the type of education delivered to each patient. A glucometer is provided for each patient in this arm to monitor blood glucose daily. Three to six visits to the community pharmacy are set during the 6-months study period. At each visit, medication related problems and self-care issues are discussed with the patient and the glucometer test strips are provided for the following month. A telephone call will be made to each patient between visits to ensure adherence to drug therapy and resolve any problems .

OTHER

Usual care

The baseline and 6-month follow-up visits to the community pharmacy will be required. If the physician prefers more visits to his office during the study period, it will be granted. The glucometer and a training session about diabetes self-care will be provide at the end of study for control group patients.

Sponsors & Collaborators

  • Research Center for Rational Use of Drugs

    collaborator UNKNOWN

  • Tehran University of Medical Sciences

    lead OTHER

Principal Investigators

  • Kheirollah Gholami, M.Sc, PharmD · Tehran University of Medical Sciences

  • Zahra Jahangard-Rafsanjani, PharmD · Tehran University of Medical Sciences

  • Arash Rashidian, MD, Ph.D · Tehran University of Medical Sciences

  • Navid Saadat, MD · Shahid Beheshti University of Medical Sciences

  • Amir Sarayani, PharmD, MPH · Tehran University of Medical Sciences

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2013-08-31
Completion
2013-09-30

Countries

  • Iran

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01525992 on ClinicalTrials.gov